Timothy (Tim) Finley

Tim’s practice focuses on antitrust and consumer protection litigation. His extensive experience encompasses the Sherman Act, unfair trade practices, mass consumer fraud, unapproved drugs and medical devices, the safety of consumer products, and data privacy. Tim has successfully managed multi-agency investigations involving the FTC, FDA, HHS, FBI, DEA, and international authorities. He draws upon decades of experience in government and private practice to give his clients an in-depth understanding of how to prevail in high-stakes matters involving the government or sophisticated private parties.

Prior to joining the Firm, Tim advised on the following matters:

• Acted as lead counsel in United States v. Castro et al., a five-week jury trial ending in criminal convictions against three defendants who had defrauded consumers out of more than USD 20 million.
• Led a series of successful prosecutions as a member of a task force that eradicated a global mail fraud industry that had stolen more than USD 1 billion from elderly and vulnerable victims.
• Investigated several multinational drug companies for off-label marketing of prescription drugs, resulting in convictions and criminal fines in excess of USD 3 billion.
• Led an eight-member interagency prosecution team during a five-week jury trial of a publicly traded medical device firm and its CEO for selling devices without FDA approval and conspiring to defraud the United States.
• Won a jury verdict following a seven-day trial of a defendant who had sold industrial bleach as a miracle cure for cancer, AIDS, diabetes, and other serious diseases.
• Represented a global brewing company in a three-month jury trial at which plaintiff sought USD 2.5 billion in damages.
• Obtained a federal court decision denying class certification in major antitrust lawsuits alleging that an American agrochemical and agricultural biotechnology corporation had monopolized genetically modified seed markets.
• Led the defense of the world’s largest food company against an archrival’s lawsuit alleging a global conspiracy to misappropriate trade secrets. Uncovered wrongdoing by plaintiff’s top executives, forcing a nuisance-value settlement.

• Attorney General’s Award for Fraud Prevention
• Attorney General’s John Marshall Award for Litigation
• Award for Excellence, Office of Inspector General, U.S. Department of Health and Human Services
• Award for Protecting Public Health, U.S. Food and Drug Administration, Office of Criminal Investigations
• Special Commendation from the Assistant Attorney General for Outstanding Service at Trial

• American Bar Association, Antitrust Section - Member
• District of Columbia Bar Association - Member